secondary-account-menu

footer-menu-component

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

zone3

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

secondary-storefront-menu

header-component

cengage:galethorndikeseo

Account Information

bundle-connector

secondary-primary-menu

footer-legal-menu-component

single-column

config

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

container

gale-footer

mega-menu

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Products

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Support

About Us

Blogs

Press Center

Events

News

Careers

Partnerships

Contact Us

Our Company

footer

FIND YOUR REP

support-order-2

footer-legal-menu

Terms of use

Privacy

Profile

Orders

Wish List

Fast Order Entry

My Account

zone1

Browse by Institution Type

Browse by Product Type

header

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

footer-social-menu-component

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

zone2

Request a Trial

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

COMP GDE TO TOXICOLOGY IN NONCLINICL DRUG DEVELOPMENT 2

Drugs & Pharmacology

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

<P><EM>A Comprehensive Guide to Toxicology in Nonclinical Drug Development, Second Edition</EM>, is a valuable reference designed to provide a complete understanding of all aspects of nonclinical toxicology in the development of small molecules and biologics. This updated edition has been reorganized and expanded to include important topics such as stem cells in nonclinical toxicology, inhalation and dermal toxicology, pitfalls in drug development, biomarkers in toxicology, and more. Thoroughly updated to reflect the latest scientific advances and with increased coverage of international regulatory guidelines, this second edition is an essential and practical resource for all toxicologists involved in nonclinical testing in industry, academic, and regulatory settings.</P>

COLFR

COLSO

COLJR

COLSR

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Dedication.
Title Page.
Copyright Page.
Contents.
List of Contributors.
Foreword.
1: Introduction.
Drug Discovery, Metabolism, And Pharmacokinetics.
2: Critical Aspects of Integrated Nonclinical Drug Development: Concepts, Strategies, and Potential Pitfalls.
3: ADME in Drug Discovery.
4: Pharmacokinetics and Toxicokinetics.
Toxicological Studies and Ind Application, and First In-Human Clinical Trial.
5: Acute, Subacute, Subchronic, and Chronic General Toxicity Testing for Preclinical Drug Development.
6: Genetic Toxicology Testing.
7: Contemporary Practices in Core Safety Pharmacology Assessments.
8: Preparation of a Preclinical Dossier to Support an Investigational New Drug (IND) Application and First-In-Human Clinical Trial.
9: Developmental and Reproductive Toxicology.
10: Immunotoxicology Assessment in Drug Developmental.
11: Juvenile Testing to Support Clinical Trials in Pediatric Population.
12: Preclinical Evaluation of Carcinogenicity Using Standard-Bred and Genetically Engineered Rodent Models.
13: Current Strategies for Abuse Liability Assessment of New Chemical Entities.
Clinical Pathology, Histopathology, and Biomarkers.
14: Clinical Pathology.
15: Best Practice in Toxicological Pathology.
16: Molecular Pathology: Applications in Nonclinical Drug Development.
17: Biomarkers in Nonclinical Drug Development.
Biostatistics, Regulatory Toxicology, and Role of Study Directors.
18: Biostatistics for Toxicologists.
19: Regulatory Toxicology.
20: Role of Study Director and Study Monitor in Drug Development Safety Studies.
Specialty Route of Administration.
21: Infusion Toxicology and Techniques.
22: Photosafety Assessment.
Nonclinical Development of Monoclonal Antibodies, Stem Cells, Oncogenic and Non-Oncogenic Drugs, Oligonucleotides, and Vaccines.
23: Preclinical Development of Monoclonal Antibodies.
24: Nonclinical Safety Assessment of Cell-Based Therapies.
25: Preclinical Development of Nononcogenic Drugs (Small and Large Molecules).
26: Preclinical Development of Oncology Drugs.
27: Preclinical Toxicology of Vaccines1.
28: Overview of the Nonclinical Development Strategies and Class-Effects of Oligonucleotide-Based Therapeutics.
Safety Evaluation of Ocular Drugs, Botanical Products, and Medicinal Devices.
29: Safety Evaluation of Ocular Drugs.
30: Nonclinical Safety Assessment of Botanical Products.
31: Biocompatibility Evaluation of Medical Devices.
Predictive Toxicology, Toxicometabolomics, Toxicogenomics, and Imaging.
32: Application of Evolving Computational and Biological Platforms for Chemical Safety Assessment.
33: Toxicometabolomics Technology and Applications.
34: Toxicogenomics in Preclinical Development.
35: Use of Imaging for Preclinical Evaluation.
Index.

A Comprehensive Guide to Toxicology in Nonclinical Drug Development.css-1p8rvzy{position:absolute;padding-left:8px;}

A Comprehensive Guide to Toxicology in Nonclinical Drug Development